Zantac (ranitidine)

MDL 2924 (federal claims dismissed); state cases continue, S.D. Fla., Judge Robin L. Rosenberg

Filings

Coordinated

Bellwethers

Settlement

Wind-down

Most claims are resolved, dismissed or closed to new filings.

Updated Apr 16, 2026. Maintained by Jacob Malherbe.

New federal cases per week

Not tracked for this tort, because its cases are not centralized in one federal court.

Litigation strength from 0 to 100. Last reviewed Jul 20, 2026. How it's set

Apr 16, 2026
Case event
A Delaware Superior Court judge threw out the remaining Delaware Zantac cases, finding plaintiffs could not meet Delaware's standard for proving cancer causation. The federal appeal was still pending.
insurancejournal.com
Oct 23, 2025
Case event
The Eleventh Circuit heard oral argument on the appeal of the federal MDL dismissal.
verusllc.com
Jul 10, 2025
Case event
The Delaware Supreme Court unanimously reversed a lower court ruling that had allowed plaintiffs' cancer experts in the Delaware Zantac cases, requiring stricter review of the science.
tavrn.ai
Oct 9, 2024
Case event
GSK agreed to pay up to $2.2 billion to resolve about 80,000 state court Zantac cases, about 93 percent of its state court docket, without admitting wrongdoing.
healthexec.com

Get Zantac developments at the top of the Monday briefing.

1+ year use · Bladder, stomach, or esophageal cancer · Pre-2020 use

From campaign criteria. Qualification depends on each firm's review.

Depo-Provera and meningioma Coordinated (MDL or JCCP), 61 new cases in 7 days
Ozempic and GLP-1 stomach injuries Coordinated (MDL or JCCP), 35 new cases in 7 days
Suboxone and tooth decay Coordinated (MDL or JCCP), 2 new cases in 7 days
Dupixent and lymphoma (CTCL) Coordinated (MDL or JCCP), 2 new cases in 7 days

Mass Tort Ad Agency runs Meta tort campaigns for plaintiff firms and can show you what this tort's audience looks like.